COPD: open trials in Norway

3 open trials have a site in Norway. Registry data; only the trial team decides who can take part.

NCT06959095
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Trial Treatment · Phase 3 · GlaxoSmithKline
Helse Bergen HF, Bergen · Sykehuset Ostfold HF, Graalum · Akershus University Hospital, Lorenskog · St. Olavs hospital HF, Trondheim
Registry updated 2026-10-05
NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Trial Treatment · Phase 3 · AstraZeneca
Vestre Viken HF, Drammen · Akershus University Hospital, Lørenskog · Skedsmo Medisinske Senter AS, Skedsmokorset · St. Olavs hospital HF, Trondheim
Registry updated 2026-10-02
NCT06401512
Digital Follow-up Program for People with Chronic Obstructive Pulmonary Disease in Primary Healthcare
Trial Treatment · Western Norway University of Applied Sciences
Western Norway University of Applied Sciences, Bergen
Registry updated 2025-01-23

This page is not medical advice. Talk to your doctor before contacting a trial.

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation